Drug Side Effects A-Z: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

All medicines have benefits and risks. The risks of medicines are the chances that something unwanted or unexpected could happen to you when you use them, such as ARTERIOVENOUS FISTULA SITE INFECTION. Side effects can be temporary or long-lasting, and vary in seriousness. It is important to monitor drugs for ARTERIOVENOUS FISTULA SITE INFECTION and any other side effects. Sometimes ARTERIOVENOUS FISTULA SITE INFECTION can be reduced with the right treatment.



Have You experienced ARTERIOVENOUS FISTULA SITE INFECTION?
What is ARTERIOVENOUS FISTULA SITE INFECTION?

Drug Side Effect Episodes associated with ARTERIOVENOUS FISTULA SITE INFECTION
chloraprep
Episodes: 1
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
daclizumab
Episodes: 1
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
dianeal
Episodes: 2
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
epogen
Episodes: 1
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
humalog
Episodes: 2
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
renagel
Episodes: 1
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
zemplar
Episodes: 6
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.We hope you found our information about b>ARTERIOVENOUS FISTULA SITE INFECTION.